Kenichi Academic Tamama

Prof. Kenichi Academic Tamama

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
ZCZoe Cesarz
Zoe Cesarz
KTKenichi Academic Tamama
Kenichi Academic Tamama
Compared with traditional 2D adherent cell culture, 3D spheroidal cell aggregates, or spheroids, are regarded as more physiological, and this technique has been exploited in the field of oncology, stem cell biology, and tissue engineering. Mesenchymal stem cells (MSCs) cultured in spheroids have enhanced anti‐inflammatory, angiogenic, and tissue reparative/regenerative effects with improved cell survival after transplantation. Cytoskeletal reorganization and drastic changes in cell morphology in MSC spheroids indicate a major difference in mechanophysical properties compared with 2D culture. Enhanced multidifferentiation potential, upregulated expression of pluripotency marker genes, and delayed replicative senescence indicate enhanced stemness in MSC spheroids. Furthermore, spheroid formation causes drastic changes in the gene expression profile of MSC in microarray analyses. In spite of these significant changes, underlying molecular mechanisms and signaling pathways triggering and sustaining these changes are largely unknown.

22 November 2010 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
KTKenichi Academic Tamama
Kenichi Academic Tamama
HKHaruhisa Kawasaki
Haruhisa Kawasaki
SKSvetoslava S. Kerpedjieva
Svetoslava S. Kerpedjieva
JGJianjun Guan
Jianjun Guan
RGRamesh K. Ganju
Ramesh K. Ganju
CSChandan K. Sen
Chandan K. Sen

1 August 2012 in Advances in Wound Care
Verified
Journal Article
Closed access
KTKenichi Academic Tamama
Kenichi Academic Tamama
SKSvetoslava S. Kerpedjieva
Svetoslava S. Kerpedjieva
Background: Although multipotential stromal cells/mesenchymal stem cell (MSCs) initially gained attention because of their ability to differentiate into multiple cell lineages, it is their capacity to produce and secrete growth factors and cytokines that makes them particularly valuable as potential cell therapeutics. The Problem: Wound healing is an intricate process consisting of several integrated stages, including angiogenesis, collagen production, and cell migration and proliferation. Coordinating these processes to ensure rapid and thorough wound healing is necessary when developing therapeutics. This coordination, however, is disrupted in chronic nonhealing wounds, wherein the impaired blood supply and resulting ischemia compromise cellular functions and make it difficult to deliver the necessary signaling molecules. Basic/Clinical Science Advances: MSCs secrete a combination of growth factors and cytokines, which have been shown to promote wound repair. This combination of growth factors and cytokines successfully induces angiogenesis, reduces inflammation, and promotes fibroblast migration and collagen production. Clinical Care Relevance: The growth factors and cytokines secreted by MSCs can be administered to wounds by either transplanting cells or, as a safer alternative, using the conditioned medium of MSCs, which contains these secreted bioactive molecules. For their success in reducing wound closure time, MSCs offer a promising option for treating chronic wounds. Still, possible undesirable effects of MSC-based therapeutics, such as keloid formation, need to be carefully studied. Conclusion: With its strong ability to secrete diverse growth factors and cytokines, MSC-based therapeutics, either with cell transplantation or the conditioned medium, offers a novel approach toward chronic nonhealing wounds.

8 February 2012 in Stem Cells and Development
Verified
Journal Article
Closed access
SKSvetoslava S. Kerpedjieva
Svetoslava S. Kerpedjieva
DKDuk Soo Kim
Duk Soo Kim
DBDominique J. Barbeau
Dominique J. Barbeau
KTKenichi Academic Tamama
Kenichi Academic Tamama
Cell therapy with adult bone marrow multipotential stromal cells/mesenchymal stem cells (MSCs) presents a promising approach to promote wound healing and tissue regeneration. The strong paracrine capability of various growth factors and cytokines is a key mechanism of MSC-mediated wound healing and tissue regeneration, and the goal of this study is to understand the underlying mechanism that supports the strong paracrine machineries in MSCs. Microarray database analyses revealed that early growth response-1 (EGR1) is highly expressed in MSCs. Our previous studies showed that epidermal growth factor (EGF) treatment induces growth factor production in MSCs in vitro. Since EGF strongly upregulates EGR1, we hypothesized that EGF receptor (EGFR)–EGR1 signaling plays a pivotal role in MSC paracrine activity. EGF treatment upregulated the gene expression of growth factors and cytokines, including EGFR ligands in a protein kinase C (PKC)- and/or mitogen-activated protein kinase–extracellular-signal-regulated kinase-dependent manner, and it was reversed by shRNA against EGR1. PKC activator phorbol 12-myristate 13-acetate enhanced EGFR tyrosyl phosphorylation and upregulated the gene expression of growth factors and cytokines in a heparin-binding EGF-like growth factor (HBEGF) inhibitor CRM197 sensitive manner, indicating an involvement of autocrined HBEGF in the downstream of PKC signaling. Moreover, stimulation with growth factors and cytokines induced the expression of EGFR ligands, presumably via EGR1 upregulation. These data indicate EGR1 as a convergence point of multiple signaling pathways, which in turn augments the production of multiple growth factors and cytokines by enhancing the autocrine signaling with EGFR ligands.

29 January 2018 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
LLLi Liu
Li Liu
SWSarah E Wheeler
Sarah E Wheeler
RVRaman Venkataramanan
Raman Venkataramanan
JRJacqueline A Rymer
Jacqueline A Rymer
APAnthony F Pizon
Anthony F Pizon
KTKenichi Academic Tamama
Kenichi Academic Tamama
Illicit drug abuse has reached an epidemic level in the United States. Drug overdose has become the leading cause of injury-related deaths since 2008 due to the recent surge of opioid overdose by heroin, controlled prescription drugs, and nonmethadone synthetic opioids. Synthetic designer drugs such as synthetic cathinones (“bath salts”) and synthetic cannabinoids (“Spice” and “K2”) continue to emerge and attract recreational users. The emergence of new drugs of abuse poses a steep challenge for clinical toxicology laboratories. Limited information about the emerging drugs and their metabolism, “rebranding” of the illicit drugs, and a lack of Food and Drug Administration-approved screening methods for these drugs contribute to this difficulty. Here we review detection methods that can aid in identifying emerging drugs of abuse One promising approach is the utilization of untargeted drug screening by mass spectrometry. Historically, gas chromatography-mass spectrometry has been the gold standard. Liquid chromatography-tandem mass spectrometry and liquid chromatography-high-resolution mass spectrometry offer improved detection capability of new drugs with simplified sample preparation, making it the new standard.

1 March 2021 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KTKenichi Academic Tamama
Kenichi Academic Tamama